Clinical Evaluation of a New Giomer Restorative System in Class V Restorations
NCT ID: NCT03153969
Last Updated: 2022-11-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
49 participants
INTERVENTIONAL
2017-08-28
2022-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
3M ESPE FiltekTM Supreme is one of the composite resin materials that will be used in this study (Group 1). This is a light-activated, flowable restorative composite.
Shofu Beautifil II LS (SI R21204) is a new type of filling material called a Giomer. This is the second composite that will be used in this study (Group 2) Giomer is a collective term for dental materials that will release ions, such as fluoride. Results from previous studies show that the released ions may have beneficial effects on the tooth, including strengthening the tooth.
In each participant, one tooth with a class V lesion will be randomized to group 1, and a second tooth with a class V lesion will be randomized to group 2. The restorations will be observed over 18 months to determine clinical acceptability.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Release of Organic Components of a GIOMER in Non-carious Cervical Lesion Restorations
NCT03637946
18-Month Clinical Evaluation of Self-Adhesive Flowable Giomer Compared to Conventional Flowable Giomer in Carious Cervical Lesions: A Randomized Clinical Trial
NCT06946134
Evaluation of Two Resin Composites and Two Adhesives for a Novel Restorative Protocol to Treat Cervical Lesions
NCT03215615
Clinical Evaluation of Four Aesthetic Restorations in Non-carious Cervical Lesions
NCT04261140
Evaluation of Bioactive Giomer Material Versus Nanohybrid Resin Composite in Deep Marginal Elevation
NCT06497231
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of this clinical trial is to evaluate the effectiveness of a new Giomer restorative system (Shofu Beautifil LS) for use in restoring non carious Class V lesions by comparing it to 3M ESPE FiltekTM Supreme in the following categories:
Clinical Assessments (Documentation at baseline, 6months and 18months):
* Surface Luster
* Surface Staining
* Marginal Staining
* Color Match
* Anatomical Form
* Marginal Adaptation
* Fracture of Material and Retention
* Radiographic Examination
* Patient's View
* Postoperative Hypersensitivity
* Recurrence of Caries
* Tooth Integrity
* Adjacent Mucosa
Sensitivity interview- assessed preoperatively (prior to anesthesia, if needed) at baseline and after restoration placement
Dentin Sclerosis Rating- assessed at baseline
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SHOFU Beautifil II LS
Composite: SHOFU Beautifil II LS, Bonding Agent: SHOFU BeautiBond
SHOFU Beautifil II LS
Placed under manufacturer's instructions
3M/ESPE Filtek Supreme
Composite: 3M/ESPE Filtek Supreme, Bonding Agent: 3M/ESPE Scotchbond Universal
3M/ESPE Filtek Supreme
Placed under manufacturer's instructions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SHOFU Beautifil II LS
Placed under manufacturer's instructions
3M/ESPE Filtek Supreme
Placed under manufacturer's instructions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must have a minimum of 2 cervical lesions in need of restoration
* Cervical lesions must provide for a minimum of 1mm thickness of restorative material while maintaining natural tooth contour
* At least 50% of lesion must be in dentin
* Coronal margin of lesion must be in enamel
Exclusion Criteria
* Systemic or local disorders that contra-indicate the dental procedures included in this study
* Evidence of xerostomia
* Evidence of severe bruxing or clenching or in need of TMJ related therapy
* Women who are pregnant or breast feeding (self-reported).
* Known allergy to resin composites or local anesthetics
* Abnormal oral soft tissue findings (e.g., open sores, lesions)
* Condition affecting salivary flow (e.g., salivary gland disorder, Sjögren's Syndrome)
* Teeth with periapical pathology or exhibiting symptoms of pulpal pathology
* Teeth that are non-vital or have had root canal therapy
* Teeth that have been pulp capped
* Teeth with near exposures on pre-operative radiographs
* Hypersensitive teeth
* Teeth with a periodontal pocket of more than 4mm with bleeding on probing
* Teeth that are used as abutments for removable partial dentures
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shofu Inc.
INDUSTRY
Tufts University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Gerard Kugel
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gerard Kugel, DMD, MS, PhD
Role: PRINCIPAL_INVESTIGATOR
Tufts University School of Dental Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tufts University School of Dental Medicine
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12486
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.